Skip to content

Opening book details…

About this Medicine article

BMET-26PHASE 2 STUDY OF VB-111, AN ANTI-CANCER GENE THERAPY, AS MONOTHERAPY FOLLOWED BY COMBINATION OF VB-111 WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA by Brenner, Andrew; Cohen, Yael; Vredenburgh, James; Peters, Katherine; Nayak, Lakshmi; Blumenthal, Deborah; Bokstein, Felix; Breitbart, Eyal; Bangio, Livnat; Sher, Naamit; Harats, Dror; Wen, Patrick is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Brenner, Andrew; Cohen, Yael; Vredenburgh, James; Peters, Katherine; Nayak, Lakshmi; Blumenthal, Deborah; Bokstein, Felix; Breitbart, Eyal; Bangio, Livnat; Sher, Naamit; Harats, Dror; Wen, Patrick
Publisher
Duke University Press; Oxford University Press; Oxford University Press (OUP) (ISSN 1522-8517)
Published
2015
Field
Medicine (Health Sciences)

More by Brenner, Andrew; Cohen, Yael; Vredenburgh, James; Peters, Katherine; Nayak, Lakshmi; Blumenthal, Deborah; Bokstein, Felix; Breitbart, Eyal; Bangio, Livnat; Sher, Naamit; Harats, Dror; Wen, Patrick

Browse all works by Brenner, Andrew; Cohen, Yael; Vredenburgh, James; Peters, Katherine; Nayak, Lakshmi; Blumenthal, Deborah; Bokstein, Felix; Breitbart, Eyal; Bangio, Livnat; Sher, Naamit; Harats, Dror; Wen, Patrick